| 摘要 |
The invention is directed to purified and isolated novel siglec polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and therapeutic and other methods employing such polypeptides, nucleic acids and antibodies. |
